Apás AL, González SN, Arena ME. 2014. Potential of goat probiotic to bind mutagens. Anaerobe, 28: 8-12
Burns AJ, Rowland IR. 2004. Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat Res, 551: 233-43.
Cai Z, Yang J, Shu X and Xiong X. 2014. Chemotherapy-associated hepatotoxicity in colorectal cancer. Vascular, 14: 15.
Caldini G, Trotta F, Villarini M, Moretti M, Pasquini R, Scassellati-Sforzolini G
, Cenci G
. 2005. Screening of potential lactobacilli antigenotoxicity by microbial and mammalian cell-based tests. Int J Food Microbiol, 102: 37-47.
Chávez-Tapia NC, González-Rodríguez m L, Jeong M, López-Ramírez Y, Barbero-Becerra V, Juárez-Hernández E, Romero-Flores J. L, Arrese M, Méndez-Sánchez N and Uribe M. 2015. Current evidence on the use of probiotics in liver diseases. J Funct Foods, 17:137-151.
Cragg GM, Newman DJ. 2005. Plants as a source of anti-cancer agents. J Ethnopharmacol, 100: 72-79.
Etebari M, Ghannadi A, Jafarian-Dehkordi A, Ahmadi F. 2012. Genotoxicity evaluation of aqueous extracts of co-toneaster discolor and Alhagi pseudalhagi by com-et assay. J Res Med Sci, 17:S237–S241.
Fazeli H, Moshtaghian J, Mirlohi M, Shirzad M. 2010. Reduction in serum lipid parameters by incorporation of a native strain of Lactobacillus Plantarum A7 in Mice. J Diabetes Metab Disord, 9: 1-7.
Jafarian A, Zolfaghari B, Shirani K. 2014. Cytotoxicity of different extracts of arial parts of Ziziphus spina-christi on Hela and MDA-MB-468 tumor cells. Adv Biomed Res, 3: 38.
Kahouli I, Tomaro-Duchesneau C, Prakash S. 2013. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives. J Med Microbiol, 62: 1107-23.
Kontek R, Drozda R, Śliwiński M, Grzegorczyk K. 2010. Genotoxicity of irinotecan and its modulation by vitamins A, C and E in human lymphocytes from healthy individuals and cancer patients. Toxicol In Vitro, 24: 417-24.
Kumar K, Sastry N, Polaki H, Mishra V. 2015. Colon Cancer Prevention through Probiotics: An Overview. J Cancer Sci Ther, 7: 081-92.
Lévesque É, Bélanger A-S, Harvey M,Couture F, Jonker D, Innocenti F, Cecchin E, Toffoli G and Guillemette C. 2013. Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens. J Pharmacol Exp Ther, 345: 95-101.
Parvez S, Malik K, Ah Kang S, Kim HY. 2006. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol, 100: 1171-85.
Pool‐Zobel BL, Münzner R, Holzapfel WH. 1993. Antigenotoxic properties of lactic acid bacteria in the S. typhimurium mutagenicity assay. Nutr Cancer, 20: 261–270.
Raman M, Ambalam P, Kondepudi KK, Pithva S, Kothari C, Patel AT
, Purama RK
, Dave JM
, Vyas BR
. 2013. Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut microbes, 4: 181-92.
Razavi-Azarkhiavi K, Behravan J, Mosaffa F, Sehatbakhsh S, Shirani K, Karimi G. 2014. Protective effects of aqueous and ethanol extracts of rosemary on H2O2-induced oxidative DNA damage in human lymphocytes by comet assay. J Complement Integr Med, 11: 27-33.
Sadeghi-Aliabadi H, Mohammadi F, Fazeli H, Mirlohi M. 2014. Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran J Basic Med Sci, 17: 815–819.
Santos A, Zanetta S, Cresteil T, Deroussent A, Pein F, Raymond E
, Vernillet L
, Risse ML
, Boige V
, Gouyette A
, Vassal G
. 2000. Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans. Clin Cancer Res, 6: 2012-20.